The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Herceptin (Trastuzumab) Market Research Report 2025
Synopsis
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
The global Herceptin (Trastuzumab) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Herceptin (Trastuzumab) include Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Herceptin (Trastuzumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herceptin (Trastuzumab).
Report Scope
The Herceptin (Trastuzumab) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Herceptin (Trastuzumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herceptin (Trastuzumab) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Genentech
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Amgen
Samsung Bioepis
Merck
Mylan
Teva Pharmaceutical
Mundipharma
Mabion
AryoGen Biopharma
Genor Biopharma
Segment by Type
Breast Cancer
Stomach Cancer
Others
Segment by Application
Hospital
Medical Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Herceptin (Trastuzumab) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Herceptin (Trastuzumab) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
The global Herceptin (Trastuzumab) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Herceptin (Trastuzumab) include Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Herceptin (Trastuzumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herceptin (Trastuzumab).
Report Scope
The Herceptin (Trastuzumab) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Herceptin (Trastuzumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herceptin (Trastuzumab) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Genentech
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Amgen
Samsung Bioepis
Merck
Mylan
Teva Pharmaceutical
Mundipharma
Mabion
AryoGen Biopharma
Genor Biopharma
Segment by Type
Breast Cancer
Stomach Cancer
Others
Segment by Application
Hospital
Medical Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Herceptin (Trastuzumab) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Herceptin (Trastuzumab) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Herceptin (Trastuzumab) Market Overview
1.1 Product Overview and Scope of Herceptin (Trastuzumab)
1.2 Herceptin (Trastuzumab) Segment by Type
1.2.1 Global Herceptin (Trastuzumab) Market Value Comparison by Type (2024-2030)
1.2.2 Breast Cancer
1.2.3 Stomach Cancer
1.2.4 Others
1.3 Herceptin (Trastuzumab) Segment by Application
1.3.1 Global Herceptin (Trastuzumab) Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Global Herceptin (Trastuzumab) Market Size Estimates and Forecasts
1.4.1 Global Herceptin (Trastuzumab) Revenue 2019-2030
1.4.2 Global Herceptin (Trastuzumab) Sales 2019-2030
1.4.3 Global Herceptin (Trastuzumab) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Herceptin (Trastuzumab) Market Competition by Manufacturers
2.1 Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Herceptin (Trastuzumab) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Herceptin (Trastuzumab) Average Price by Manufacturers (2019-2024)
2.4 Global Herceptin (Trastuzumab) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Herceptin (Trastuzumab), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Herceptin (Trastuzumab), Product Type & Application
2.7 Herceptin (Trastuzumab) Market Competitive Situation and Trends
2.7.1 Herceptin (Trastuzumab) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Herceptin (Trastuzumab) Players Market Share by Revenue
2.7.3 Global Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Herceptin (Trastuzumab) Retrospective Market Scenario by Region
3.1 Global Herceptin (Trastuzumab) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Herceptin (Trastuzumab) Global Herceptin (Trastuzumab) Sales by Region: 2019-2030
3.2.1 Global Herceptin (Trastuzumab) Sales by Region: 2019-2024
3.2.2 Global Herceptin (Trastuzumab) Sales by Region: 2025-2030
3.3 Global Herceptin (Trastuzumab) Global Herceptin (Trastuzumab) Revenue by Region: 2019-2030
3.3.1 Global Herceptin (Trastuzumab) Revenue by Region: 2019-2024
3.3.2 Global Herceptin (Trastuzumab) Revenue by Region: 2025-2030
3.4 North America Herceptin (Trastuzumab) Market Facts & Figures by Country
3.4.1 North America Herceptin (Trastuzumab) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Herceptin (Trastuzumab) Sales by Country (2019-2030)
3.4.3 North America Herceptin (Trastuzumab) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Herceptin (Trastuzumab) Market Facts & Figures by Country
3.5.1 Europe Herceptin (Trastuzumab) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Herceptin (Trastuzumab) Sales by Country (2019-2030)
3.5.3 Europe Herceptin (Trastuzumab) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Herceptin (Trastuzumab) Market Facts & Figures by Country
3.6.1 Asia Pacific Herceptin (Trastuzumab) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Herceptin (Trastuzumab) Sales by Country (2019-2030)
3.6.3 Asia Pacific Herceptin (Trastuzumab) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Herceptin (Trastuzumab) Market Facts & Figures by Country
3.7.1 Latin America Herceptin (Trastuzumab) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Herceptin (Trastuzumab) Sales by Country (2019-2030)
3.7.3 Latin America Herceptin (Trastuzumab) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Herceptin (Trastuzumab) Market Facts & Figures by Country
3.8.1 Middle East and Africa Herceptin (Trastuzumab) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Herceptin (Trastuzumab) Sales by Type (2019-2030)
4.1.1 Global Herceptin (Trastuzumab) Sales by Type (2019-2024)
4.1.2 Global Herceptin (Trastuzumab) Sales by Type (2025-2030)
4.1.3 Global Herceptin (Trastuzumab) Sales Market Share by Type (2019-2030)
4.2 Global Herceptin (Trastuzumab) Revenue by Type (2019-2030)
4.2.1 Global Herceptin (Trastuzumab) Revenue by Type (2019-2024)
4.2.2 Global Herceptin (Trastuzumab) Revenue by Type (2025-2030)
4.2.3 Global Herceptin (Trastuzumab) Revenue Market Share by Type (2019-2030)
4.3 Global Herceptin (Trastuzumab) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Herceptin (Trastuzumab) Sales by Application (2019-2030)
5.1.1 Global Herceptin (Trastuzumab) Sales by Application (2019-2024)
5.1.2 Global Herceptin (Trastuzumab) Sales by Application (2025-2030)
5.1.3 Global Herceptin (Trastuzumab) Sales Market Share by Application (2019-2030)
5.2 Global Herceptin (Trastuzumab) Revenue by Application (2019-2030)
5.2.1 Global Herceptin (Trastuzumab) Revenue by Application (2019-2024)
5.2.2 Global Herceptin (Trastuzumab) Revenue by Application (2025-2030)
5.2.3 Global Herceptin (Trastuzumab) Revenue Market Share by Application (2019-2030)
5.3 Global Herceptin (Trastuzumab) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Corporation Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Diagnostics Herceptin (Trastuzumab) Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 Genentech
6.2.1 Genentech Corporation Information
6.2.2 Genentech Description and Business Overview
6.2.3 Genentech Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Genentech Herceptin (Trastuzumab) Product Portfolio
6.2.5 Genentech Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Herceptin (Trastuzumab) Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Herceptin (Trastuzumab) Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Abnova Corporation
6.5.1 Abnova Corporation Corporation Information
6.5.2 Abnova Corporation Description and Business Overview
6.5.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abnova Corporation Herceptin (Trastuzumab) Product Portfolio
6.5.5 Abnova Corporation Recent Developments/Updates
6.6 InvivoGen
6.6.1 InvivoGen Corporation Information
6.6.2 InvivoGen Description and Business Overview
6.6.3 InvivoGen Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 InvivoGen Herceptin (Trastuzumab) Product Portfolio
6.6.5 InvivoGen Recent Developments/Updates
6.7 Celltrion
6.6.1 Celltrion Corporation Information
6.6.2 Celltrion Description and Business Overview
6.6.3 Celltrion Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Celltrion Herceptin (Trastuzumab) Product Portfolio
6.7.5 Celltrion Recent Developments/Updates
6.8 Biocon Limited
6.8.1 Biocon Limited Corporation Information
6.8.2 Biocon Limited Description and Business Overview
6.8.3 Biocon Limited Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biocon Limited Herceptin (Trastuzumab) Product Portfolio
6.8.5 Biocon Limited Recent Developments/Updates
6.9 Bio-Techne
6.9.1 Bio-Techne Corporation Information
6.9.2 Bio-Techne Description and Business Overview
6.9.3 Bio-Techne Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bio-Techne Herceptin (Trastuzumab) Product Portfolio
6.9.5 Bio-Techne Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Corporation Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Amgen Herceptin (Trastuzumab) Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 Samsung Bioepis
6.11.1 Samsung Bioepis Corporation Information
6.11.2 Samsung Bioepis Herceptin (Trastuzumab) Description and Business Overview
6.11.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Samsung Bioepis Herceptin (Trastuzumab) Product Portfolio
6.11.5 Samsung Bioepis Recent Developments/Updates
6.12 Merck
6.12.1 Merck Corporation Information
6.12.2 Merck Herceptin (Trastuzumab) Description and Business Overview
6.12.3 Merck Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Merck Herceptin (Trastuzumab) Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Mylan
6.13.1 Mylan Corporation Information
6.13.2 Mylan Herceptin (Trastuzumab) Description and Business Overview
6.13.3 Mylan Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Mylan Herceptin (Trastuzumab) Product Portfolio
6.13.5 Mylan Recent Developments/Updates
6.14 Teva Pharmaceutical
6.14.1 Teva Pharmaceutical Corporation Information
6.14.2 Teva Pharmaceutical Herceptin (Trastuzumab) Description and Business Overview
6.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolio
6.14.5 Teva Pharmaceutical Recent Developments/Updates
6.15 Mundipharma
6.15.1 Mundipharma Corporation Information
6.15.2 Mundipharma Herceptin (Trastuzumab) Description and Business Overview
6.15.3 Mundipharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Mundipharma Herceptin (Trastuzumab) Product Portfolio
6.15.5 Mundipharma Recent Developments/Updates
6.16 Mabion
6.16.1 Mabion Corporation Information
6.16.2 Mabion Herceptin (Trastuzumab) Description and Business Overview
6.16.3 Mabion Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Mabion Herceptin (Trastuzumab) Product Portfolio
6.16.5 Mabion Recent Developments/Updates
6.17 AryoGen Biopharma
6.17.1 AryoGen Biopharma Corporation Information
6.17.2 AryoGen Biopharma Herceptin (Trastuzumab) Description and Business Overview
6.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolio
6.17.5 AryoGen Biopharma Recent Developments/Updates
6.18 Genor Biopharma
6.18.1 Genor Biopharma Corporation Information
6.18.2 Genor Biopharma Herceptin (Trastuzumab) Description and Business Overview
6.18.3 Genor Biopharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Genor Biopharma Herceptin (Trastuzumab) Product Portfolio
6.18.5 Genor Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Herceptin (Trastuzumab) Industry Chain Analysis
7.2 Herceptin (Trastuzumab) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Herceptin (Trastuzumab) Production Mode & Process
7.4 Herceptin (Trastuzumab) Sales and Marketing
7.4.1 Herceptin (Trastuzumab) Sales Channels
7.4.2 Herceptin (Trastuzumab) Distributors
7.5 Herceptin (Trastuzumab) Customers
8 Herceptin (Trastuzumab) Market Dynamics
8.1 Herceptin (Trastuzumab) Industry Trends
8.2 Herceptin (Trastuzumab) Market Drivers
8.3 Herceptin (Trastuzumab) Market Challenges
8.4 Herceptin (Trastuzumab) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Herceptin (Trastuzumab) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Herceptin (Trastuzumab) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Herceptin (Trastuzumab) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Herceptin (Trastuzumab) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Herceptin (Trastuzumab) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Herceptin (Trastuzumab) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Herceptin (Trastuzumab), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Herceptin (Trastuzumab), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Herceptin (Trastuzumab), Product Type & Application
Table 12. Global Key Manufacturers of Herceptin (Trastuzumab), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Herceptin (Trastuzumab) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herceptin (Trastuzumab) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Herceptin (Trastuzumab) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Herceptin (Trastuzumab) Sales by Region (2019-2024) & (K Units)
Table 18. Global Herceptin (Trastuzumab) Sales Market Share by Region (2019-2024)
Table 19. Global Herceptin (Trastuzumab) Sales by Region (2025-2030) & (K Units)
Table 20. Global Herceptin (Trastuzumab) Sales Market Share by Region (2025-2030)
Table 21. Global Herceptin (Trastuzumab) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2019-2024)
Table 23. Global Herceptin (Trastuzumab) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2025-2030)
Table 25. North America Herceptin (Trastuzumab) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Herceptin (Trastuzumab) Sales by Country (2019-2024) & (K Units)
Table 27. North America Herceptin (Trastuzumab) Sales by Country (2025-2030) & (K Units)
Table 28. North America Herceptin (Trastuzumab) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Herceptin (Trastuzumab) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Herceptin (Trastuzumab) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Herceptin (Trastuzumab) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Herceptin (Trastuzumab) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Herceptin (Trastuzumab) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Herceptin (Trastuzumab) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Herceptin (Trastuzumab) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Herceptin (Trastuzumab) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Herceptin (Trastuzumab) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Herceptin (Trastuzumab) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Herceptin (Trastuzumab) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Herceptin (Trastuzumab) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Herceptin (Trastuzumab) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Herceptin (Trastuzumab) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Herceptin (Trastuzumab) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Herceptin (Trastuzumab) Sales (K Units) by Type (2019-2024)
Table 51. Global Herceptin (Trastuzumab) Sales (K Units) by Type (2025-2030)
Table 52. Global Herceptin (Trastuzumab) Sales Market Share by Type (2019-2024)
Table 53. Global Herceptin (Trastuzumab) Sales Market Share by Type (2025-2030)
Table 54. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2019-2024)
Table 57. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2025-2030)
Table 58. Global Herceptin (Trastuzumab) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Herceptin (Trastuzumab) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Herceptin (Trastuzumab) Sales (K Units) by Application (2019-2024)
Table 61. Global Herceptin (Trastuzumab) Sales (K Units) by Application (2025-2030)
Table 62. Global Herceptin (Trastuzumab) Sales Market Share by Application (2019-2024)
Table 63. Global Herceptin (Trastuzumab) Sales Market Share by Application (2025-2030)
Table 64. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2019-2024)
Table 67. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2025-2030)
Table 68. Global Herceptin (Trastuzumab) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Herceptin (Trastuzumab) Price (USD/Unit) by Application (2025-2030)
Table 70. Roche Diagnostics Corporation Information
Table 71. Roche Diagnostics Description and Business Overview
Table 72. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Roche Diagnostics Herceptin (Trastuzumab) Product
Table 74. Roche Diagnostics Recent Developments/Updates
Table 75. Genentech Corporation Information
Table 76. Genentech Description and Business Overview
Table 77. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Genentech Herceptin (Trastuzumab) Product
Table 79. Genentech Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Novartis AG Herceptin (Trastuzumab) Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Herceptin (Trastuzumab) Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Abnova Corporation Corporation Information
Table 91. Abnova Corporation Description and Business Overview
Table 92. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Abnova Corporation Herceptin (Trastuzumab) Product
Table 94. Abnova Corporation Recent Developments/Updates
Table 95. InvivoGen Corporation Information
Table 96. InvivoGen Description and Business Overview
Table 97. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. InvivoGen Herceptin (Trastuzumab) Product
Table 99. InvivoGen Recent Developments/Updates
Table 100. Celltrion Corporation Information
Table 101. Celltrion Description and Business Overview
Table 102. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Celltrion Herceptin (Trastuzumab) Product
Table 104. Celltrion Recent Developments/Updates
Table 105. Biocon Limited Corporation Information
Table 106. Biocon Limited Description and Business Overview
Table 107. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Biocon Limited Herceptin (Trastuzumab) Product
Table 109. Biocon Limited Recent Developments/Updates
Table 110. Bio-Techne Corporation Information
Table 111. Bio-Techne Description and Business Overview
Table 112. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Bio-Techne Herceptin (Trastuzumab) Product
Table 114. Bio-Techne Recent Developments/Updates
Table 115. Amgen Corporation Information
Table 116. Amgen Description and Business Overview
Table 117. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Amgen Herceptin (Trastuzumab) Product
Table 119. Amgen Recent Developments/Updates
Table 120. Samsung Bioepis Corporation Information
Table 121. Samsung Bioepis Description and Business Overview
Table 122. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Samsung Bioepis Herceptin (Trastuzumab) Product
Table 124. Samsung Bioepis Recent Developments/Updates
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Merck Herceptin (Trastuzumab) Product
Table 129. Merck Recent Developments/Updates
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Business Overview
Table 132. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Mylan Herceptin (Trastuzumab) Product
Table 134. Mylan Recent Developments/Updates
Table 135. Teva Pharmaceutical Corporation Information
Table 136. Teva Pharmaceutical Description and Business Overview
Table 137. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Teva Pharmaceutical Herceptin (Trastuzumab) Product
Table 139. Teva Pharmaceutical Recent Developments/Updates
Table 140. Mundipharma Corporation Information
Table 141. Mundipharma Description and Business Overview
Table 142. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Mundipharma Herceptin (Trastuzumab) Product
Table 144. Mundipharma Recent Developments/Updates
Table 145. Mabion Corporation Information
Table 146. Mabion Description and Business Overview
Table 147. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Mabion Herceptin (Trastuzumab) Product
Table 149. Mabion Recent Developments/Updates
Table 150. AryoGen Biopharma Corporation Information
Table 151. AryoGen Biopharma Description and Business Overview
Table 152. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. AryoGen Biopharma Herceptin (Trastuzumab) Product
Table 154. AryoGen Biopharma Recent Developments/Updates
Table 155. Genor Biopharma Corporation Information
Table 156. Genor Biopharma Description and Business Overview
Table 157. Genor Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Genor Biopharma Herceptin (Trastuzumab) Product
Table 159. Genor Biopharma Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Herceptin (Trastuzumab) Distributors List
Table 163. Herceptin (Trastuzumab) Customers List
Table 164. Herceptin (Trastuzumab) Market Trends
Table 165. Herceptin (Trastuzumab) Market Drivers
Table 166. Herceptin (Trastuzumab) Market Challenges
Table 167. Herceptin (Trastuzumab) Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Herceptin (Trastuzumab)
Figure 2. Global Herceptin (Trastuzumab) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Herceptin (Trastuzumab) Market Share by Type in 2023 & 2030
Figure 4. Breast Cancer Product Picture
Figure 5. Stomach Cancer Product Picture
Figure 6. Others Product Picture
Figure 7. Global Herceptin (Trastuzumab) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Herceptin (Trastuzumab) Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Medical Center
Figure 11. Global Herceptin (Trastuzumab) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Herceptin (Trastuzumab) Market Size (2019-2030) & (US$ Million)
Figure 13. Global Herceptin (Trastuzumab) Sales (2019-2030) & (K Units)
Figure 14. Global Herceptin (Trastuzumab) Average Price (USD/Unit) & (2019-2030)
Figure 15. Herceptin (Trastuzumab) Report Years Considered
Figure 16. Herceptin (Trastuzumab) Sales Share by Manufacturers in 2023
Figure 17. Global Herceptin (Trastuzumab) Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Herceptin (Trastuzumab) Players: Market Share by Revenue in 2023
Figure 19. Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Herceptin (Trastuzumab) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Herceptin (Trastuzumab) Sales Market Share by Country (2019-2030)
Figure 22. North America Herceptin (Trastuzumab) Revenue Market Share by Country (2019-2030)
Figure 23. United States Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Herceptin (Trastuzumab) Sales Market Share by Country (2019-2030)
Figure 26. Europe Herceptin (Trastuzumab) Revenue Market Share by Country (2019-2030)
Figure 27. Germany Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Herceptin (Trastuzumab) Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Herceptin (Trastuzumab) Revenue Market Share by Region (2019-2030)
Figure 34. China Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Herceptin (Trastuzumab) Sales Market Share by Country (2019-2030)
Figure 44. Latin America Herceptin (Trastuzumab) Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Herceptin (Trastuzumab) Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Herceptin (Trastuzumab) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Herceptin (Trastuzumab) by Type (2019-2030)
Figure 54. Global Revenue Market Share of Herceptin (Trastuzumab) by Type (2019-2030)
Figure 55. Global Herceptin (Trastuzumab) Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Herceptin (Trastuzumab) by Application (2019-2030)
Figure 57. Global Revenue Market Share of Herceptin (Trastuzumab) by Application (2019-2030)
Figure 58. Global Herceptin (Trastuzumab) Price (USD/Unit) by Application (2019-2030)
Figure 59. Herceptin (Trastuzumab) Value Chain
Figure 60. Herceptin (Trastuzumab) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
